English

Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

询价与订购

  • Name*

  • Phone*

  • Email*

  • Product*

  • Content*

Anti-IL23A重组抗体|科研级 Risankizumab ( 利散吉珠单抗 )

CatNo:TKYR1385

  • 1mg
  • 5mg
WeChat QR
Contact Us
instructions
MSDS
WeChat QR
Contact Us
  • Detailed
  • Background
  • Plan&FAQ
  • Related
  • Recommended
  • Detailed related information

    Catalog Number

    TKYR1385

    Alias

    科研级 Risankizumab ( 利散吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Risankizumab

    Molecular Name

    Risankizumab

    Size

    1mg, 5mg

    CAS Number

    1612838-76-2

    Isotype

    IgG1 Kappa

    Clonality

    Monoclonal

    Concentration

    1mg/ml

    Source

    CHO Cells

    Purity

    ≥95% as determined by SDS-PAGE

    Buffer

    Supplied in PBS, PH7.5

    Protein Chemical Formula

    C6476H9992N1720O2016S44

    Target

    IL23A[Homo sapiens]

    Background

    Risankizumab, sold under the brand name Skyrizi, is a humanized monoclonal antibody targeting interleukin 23A (IL-23A). Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie.

    Storage

    该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。

    NOTE

    仅科研使用
    Target background information
    Experimental Plan&FAQ

    To experience the reliable service of Tekbiotech please subscribe: